Global Continuous Renal Replacement Therapy (CRRT)Market to reach USD 1.8billion by 2027.
Global Continuous Renal Replacement Therapy (CRRT)Market is valued approximately at USD 1.1billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.3% over the forecast period 2021-2027.

Continuous renal replacement therapy, commonly known as a blood purification therapyis primarilyadopted to offer renal support to critically ill patients who have acute kidney injuries, mainly patients who are hemodynamically unstable. The global continuous renal replacement therapy (CRRT)marketis being driven byrising incidences of acute kidney injury, increasing prevalence of hypertension and diabetes, clinical advantagesoffered by CRRT over intermittent blood purification, technological developments worldwide, etc. As per the National Center for Biotechnology Information (United States National Library of Medicine, National Institutes of Health), article 2019, nearly 5%-10% of patients with acute kidney injury need renal replacement therapy during their stay at ICU, and with mortality rate ranging between 30% and 70%.Further, according to the International Society of Nephrology, about 13.3 million cases ofacute kidney injuryare witnessed each year with nearly 11.3 million in emerging economies. In addition, about 1.7 milliondeaths are caused due to acute kidney injury worldwide out of which, nearly 0.4 million deaths are caused in low and middle income countries. Such prevalence of acute kidney injury increases the requirement forcontinuousrenal replacement therapy which drives the market.
The regional analysis of the global Continuous Renal Replacement TherapyMarket is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North Americais the leadingregion across the world in terms of market share due to prevalence of kidney related disorders, incidences of acute kidney injury across the region. Whereas Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027due to prevalence of hypertension, diabetes, and chronic kidney disease,improvement of healthcare infrastructure and expenditureacross the region.
Major market player included in this report are:
Baxter International Inc.
Fresenius Medical Care AG & Co. KGaA
NIKKISO CO., LTD.
B. Braun Melsungen AG
Asahi Kasei Corporation
Toray Medical Co., Ltd.
Infomed SA
Medtronic plc
Medica S.p.A.
Medical Components, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

ByProduct Type:
Dialysates and Replacement Fluids
Disposables
Hemofilters
Bloodline Sets & Tubes
CRRT Systems
Other Disposables
By Modality:
Continuous venovenous hemofiltration
Continuous venovenous hemodiafiltration
Continuous venovenous haemodialysis
Slow continuous ultrafiltration
By Age group:
Adults
Pediatrics /Neonates
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Continuous Renal Replacement Therapy (CRRT) Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors